About Pearl Pathways
Pearl Pathways is a company based in Indianapolis (United States) founded in 2010 was acquired by Versiti in November 2023. Pearl Pathways offers products and services including Regulatory Services, Quality Compliance Services, and Clinical Services. Pearl Pathways operates in a competitive market with competitors including Celgene, Syneos Health, Medelis WCCT Global, Parexel and PRA Health Sciences, among others.
- Headquarter Indianapolis, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Pearl Pathways, Llc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Pearl Pathways
Pearl Pathways offers a comprehensive portfolio of products and services, including Regulatory Services, Quality Compliance Services, and Clinical Services.
Assists with strategy and filings for drug development.
Provides auditing and supplier management for life sciences.
Offers trial management and medical writing services.
People of Pearl Pathways
Unlock access to complete
Funding Insights of Pearl Pathways
Detailed funding history for Pearl Pathways
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Pearl Pathways
Pearl Pathways has secured backing from 1 investor. Prominent investors backing the company include Versiti.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Blood bank
|
Locked | Locked | Locked |
Investor details for Pearl Pathways
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Pearl Pathways
Investment portfolio details for Pearl Pathways
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Pearl Pathways
Detailed financials for Pearl Pathways
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pearl Pathways Comparisons
Peer comparison for Pearl Pathways
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Pearl Pathways
Pearl Pathways operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celgene, Syneos Health, Medelis WCCT Global, Parexel and PRA Health Sciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapies for cancer and inflammatory diseases are developed.
|
|
| Locked | Locked | Locked |
CRO clinical development services are provided by Syneos Health.
|
|
| Locked | Locked | Locked |
Full-service CRO expertise in influenza and oncology research is offered.
|
|
| Locked | Locked | Locked |
Full-service clinical research organization services are provided globally by Parexel.
|
|
| Locked | Locked | Locked |
Global full-service CRO services are delivered in over 80 countries.
|
|
| Locked | Locked | Locked |
Outsourced contract research organization services are provided to clients.
|
Detailed competitors of Pearl Pathways
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pearl Pathways
Complete news archive for Pearl Pathways
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pearl Pathways
Pearl Pathways was founded in 2010.
Pearl Pathways is headquartered in Indianapolis, United States. It is registered at Indianapolis, Indiana, United States.
Pearl Pathways is a clinical CRO offering services for biopharmaceutical, medical device, and diagnostic companies. Their service portfolio includes global feasibility, study start-up, document management, project management, clinical trial monitoring, regulatory affairs management, clinical data management and biostatistics, safety and quality assurance services. Pearl IRB, their independent review board is accredited by the Association for the Accreditation of Human Research Protection Program Inc. (AAHRPP) and thus the company has capabilities to offer IRB board review services, patient recruitment materials and advertisements, expedited and full board ICFprotocol reviews, among others.
Pearl Pathways's top competitors include Emmes, Syneos Health and ClinChoice.
Pearl Pathways offers Regulatory Services, Quality Compliance Services, and Clinical Services.
Pearl Pathways has 1 investor. Key investors include Versiti.